Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity

BACKGROUND: Aspirin has recently emerged as an anticancer drug, but its therapeutic effect on lung cancer has been rarely reported, and the mechanism of action is still unclear. Long-term use of celecoxib in large doses causes serious side effects, and it is necessary to explore better ways to achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiangyu, Chen, Jia, Cheng, Cheng, Li, Ping, Cai, Fangfang, Xu, Huangru, Lu, Yanyan, Cao, Nini, Liu, Jia, Wang, Jigang, Hua, Zi-Chun, Zhuang, Hongqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502795/
https://www.ncbi.nlm.nih.gov/pubmed/32994805
http://dx.doi.org/10.1177/1758835920947976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502795/
https://www.ncbi.nlm.nih.gov/pubmed/32994805
http://dx.doi.org/10.1177/1758835920947976

Ejemplares similares